Share on LinkedInShare on LinkedIn

ARTICLE · 04 JULY 2019

Confidential Treatment Process Gets Easier

WilmerHale
WilmerHale
Contributor
WilmerHale

WilmerHale

WilmerHale's London office was established more than 40 years ago. With lawyers qualified in the...

View firm profile
Explore more from WilmerHale

The SEC has approved rule changes that significantly simplify the process for public companies to redact confidential information from the exhibits required to be filed as part of SEC reports and registration statements.

United StatesCorporate/Commercial Law

The SEC has approved rule changes that significantly simplify the process for public companies to redact confidential information from the exhibits required to be filed as part of SEC reports and registration statements. These welcome changes were made as part of the FAST Act Modernization and Simplification of Regulation S-K rule amendments approved by the SEC in late March.

Although the confidential treatment process has been made easier, the substantive rules regarding when confidential information may be omitted from an exhibit have not changed and companies need to continue to exercise appropriate judgment at the time of filing to determine what information may be redacted.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from